Work

Preclinical Efficacy Evaluations of XK-469: Dose Schedule, Route and Cross-Resistance Behavior in Tumor Bearing Mice

Year: 2002

Type: article

Source: Investigational New Drugs

DOI: 10.1023/a:1014469828729

Authors: Lisa Polin, Kathryn White, Juiwanna Kushner, Jennifer Paluch, Chiab Simpson, Susan Pugh, Matthew K. Edelstein, Stuart Hazeldine, Joseph Fontana, Patricia LoRusso, Jerome P. Horwitz, Thomas H. Corbett

Institutions: Wayne State University, The Barbara Ann Karmanos Cancer Institute, John D. Dingell VA Medical Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Barbara Ann Karmanos Cancer Institute, National Institutes of Health, National Cancer Institute

Awards: THERAPEUTICS OF NEW SOLID TUMOR ANTICANCER AGENTS, G2477248716, G5372431793, OPTIMIZATION OF XK469 AGAINST TRANSPLANTED SOLID TUMORS

OpenAlex ID: W57553398

FWCI: 0.324

Cites: 12

Cited by: 16

Related to: 10